Cover Image

Therapeutic drug monitoring of vancomycin by AUCτ-MIC ratio in patients with chronic kidney disease

In this study which was conducted in Alzahra University Hospital (Isfahan, I.R. Iran), the therapeutic drug monitoring of vancomycin focused on determining area under the concentration-time curve at dosing interval (τ) at steady state/minimum inhibitory concentration (AUCτ/MIC) was carried out in ch...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahmad Khoei (Author), Rasool Soltani (Author), Jaber Emami (Author), Shirinsadat Badri (Author), Shahram Taheri (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
by: Seenae Eum, et al.
Published: (2016)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
by: Wasan Katip, et al.
Published: (2021)

Evaluation of traditional initial vancomycin dosing versus utilizing an electronic AUC/MIC dosing program
by: Kerri A. McGrady, et al.
Published: (2020)

Vitamin E in the prevention of vancomycin-induced nephrotoxicity
by: Rasool Soltani, et al.
Published: (2020)

Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible
by: Kashif Hussain, et al.
Published: (2022)

The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients
by: Jihui Chen, et al.
Published: (2021)

Evaluation of the Association between Trough and Area Under the Curve to Minimum Inhibitory Concentration Ratio (AUC24/MIC) of Vancomycin in Infected Patients with Methicillin Resistant Staphylococcus aureus (MRSA)
by: Ayda Esmaeili, et al.
Published: (2021)

Is it time to recommend AUC-based vancomycin therapeutic drug monitoring only? A cross-sectional survey in China
by: Jieqiong Liu, et al.
Published: (2024)

Association of vancomycin-induced acute kidney injury with trough versus AUC monitoring in patients receiving extended durations of therapy
by: C. Tyler Pitcock, et al.
Published: (2023)

Impact of Τh1 and Τh2 cytokines in the progression of idiopathic nephrotic syndrome due to focal segmental glomerulosclerosis and minimal change disease
by: Maria Stangou, et al.
Published: (2017)

Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia
by: Sameerah Aljohani, et al.
Published: (2020)

Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations
by: Kritsaporn Sujjavorakul, et al.
Published: (2023)

Determination of nucleoside DOT1L inhibitors' residence times by τRAMD simulations
by: Carlos D. Flores-León, et al.
Published: (2023)

Therapeutic monitoring of vancomycin = Monitorização terapêutica da vancomicina
by: Sergio Seiji Yamada, et al.
Published: (2012)

Herbal supplement use and herb-drug interactions among patients with kidney disease
by: Soroush Mohammadi, et al.
Published: (2020)

Ganciclovir use evaluation in kidney transplantation departments
by: Maryam Mozaffar, et al.
Published: (2016)

Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
by: Eric R. Gregory, et al.
Published: (2022)

Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency
by: Said Abuhasna, et al.
Published: (2011)

Estimation of MBC: MIC Ratio of Herbal Extracts against Common Endodontic Pathogens
by: Shenoi Pratima R, et al.
Published: (2024)

Molecular characterisation and epidemiology of transmission of intraoperative Staphylococcus aureus isolates stratified by vancomycin minimum inhibitory concentration (MIC)
by: Brent Hadder, et al.
Published: (2022)

Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
by: Dae Il Kim, et al.
Published: (2010)

Vancomycin AUC-Based Dosing Practices in a Non-Teaching Community Hospital and Associated Outcomes: A One-Year Survey of Uniform Targets for Infections with or without MRSA
by: Iftekharul Islam
Published: (2024)

Population Pharmacokinetic Analysis of Pazopanib in Patients and Determination of Target AUC
by: Agustos Cetin Ozbey, et al.
Published: (2021)

Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the "MIC Creep" Phenomenon
by: Eko Setiawan, et al.
Published: (2019)

Rising incidence of high MIC for vancomycin among Staphylococcus aureus strains at a tertiary care hospital in South India
by: Banda Venkata Ramana, et al.
Published: (2012)

Τhe Impact of Training Environmental Educators: Environmental Perceptions and Attitudes of Pre-Primary and Primary School Teachers in Greece
by: Dafni Petkou, et al.
Published: (2021)

Therapeutic Drug Monitoring for Evaluation of the Efficacy and Safety of Vancomycin in Patients with Orthopaedic Infections
by: O. S. Tufanova, et al.
Published: (2022)

Application of Machine Learning Classification to Improve the Performance of Vancomycin Therapeutic Drug Monitoring
by: Sooyoung Lee, et al.
Published: (2022)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
by: Nicole Bradley, et al.
Published: (2023)

Nephrotoxicity induced by vascular endothelial growth factor inhibitors
by: Shirinsadat Badri, et al.
Published: (2022)

Optimization of therapeutic drug monitoring of vancomycin in newborns using "Dried Blood Spot" method
by: V. I. Petrov, et al.
Published: (2024)

Measuring and improving the timeliness of vancomycin therapeutic drug monitoring and potential patient safety impacts
by: Belinda Chappell, et al.
Published: (2024)

Evaluating nivolumab plus gemcitabine-cisplatin's cost-effectiveness for aUC in China
by: Kehui Meng, et al.
Published: (2024)

Potential of drug interactions as a cause of adverse drug reactions in patients with kidney diseases
by: Tahereh Gholipur Shahraki, et al.
Published: (2020)

Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort
by: Juhaina Salim Al-Maqbali, et al.
Published: (2022)

Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring
by: Ashley Chen, et al.
Published: (2022)

Awareness, perception, and barriers of healthcare providers toward the revised consensus guideline for therapeutic monitoring of vancomycin
by: Sarah S. Alghanem, et al.
Published: (2023)

Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults
by: Heleen Gastmans, et al.
Published: (2022)

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
by: Kashif Hussain, et al.
Published: (2021)

Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with UGT2B7 polymorphisms
by: Pithukpakorn M, et al.
Published: (2014)